Abstract:Photodynamic therapy (PDT) is a promising strategy for cancer treatment. It can not only generate reactive oxygen species (ROS) to cause the chemical damage of tumor cells in the presence of enough oxygen but also promote the antitumor immunity of T cells through enhancing the production of interferon γ (IFN-γ). However, one phenomenon is ignored so far that the enhanced production of IFN-γ caused by PDT may significantly increase the expression of programmed death-ligand 1 (PD-L1) on the tumor cell membrane and thus could inhibit the immune killing effects of T cells. Herein, we report the construction of a composite by loading metformin (Met) and IR775 into a clinically usable liposome as a two-in-one nanoplatform (@Lip) to solve this problem. The @Lip could reverse tumor hypoxia to enhance ROS production to elicit more chemical damage. Besides, the overexpression of PD-L1 by PDT was also effectively down-regulated. These therapeutic benefits including decreased PD-L1 expression, alleviated T cell exhaustion, and reversed tumor hypoxia successfully suppressed both the primary and abscopal tumor growth in bladder and colon cancers, respectively. Combining with its excellent biocompatibility, our results indicate that this @Lip system has great potential to become a highly effective cancer therapy modality.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsami.0c21743?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsami.0c21743</a>.UV–vis spectra of Met, , IR775, and ; dilution and storage stability analysis of @Lip; chromatogram of Met; standard curve of Met and IR775; cellular uptake of @Lip; representative immunofluorescence images of pimonidazole; flow cytometry results of ROS in MB49 cells; cell viability of CT26 cells after different treatments; immunofluorescence images of PD-L1 in MB49 and CT26 cells; Western blot analysis of the expression of PD-L1 in MB49 and CT26 cells; flow cytometry analysis of the expression of PD-L1 in MB49 and CT26 cells; analysis of the expression of PD-L1 in the CT26 tumor model by Western blotting; immunofluorescence images of CD3+, CD4+, and CD8+ T cells in CT26 tumors; expression of IFN-γ in the MB49 and CT26 tumor tissues; photograph of collected MB49 and CT26 tumors after different treatments; relative body weight of MB49 and CT26 tumor-bearing mice after different treatments; representative images of Ki67, TUNEL, and H&E staining in the MB49 and CT26 tumors after different treatments; expression of IFN-γ in the MB49 tumor tissues after antitumor treatment; biosafety evaluation of @Lip; The primary tumor growth curves for MB49 tumor-bearing mice after different treatments; distal tumor growth curves of each mouse in different treatment groups (<a class="ext-link" href="/doi/suppl/10.1021/acsami.0c21743/suppl_file/am0c21743_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Metformin-Mediated Fast Charge-Reversal Nanohybrid for Deep Penetration Piezocatalysis-Augmented Chemodynamic Immunotherapy of Cancer

Bimetallic Peroxide-Based Nanotherapeutics for Immunometabolic Intervention and Induction of Immunogenic Cell Death to Augment Cancer Immunotherapy

Metformin-Induced Stromal Depletion to Enhance the Penetration of Gemcitabine-Loaded Magnetic Nanoparticles for Pancreatic Cancer Targeted Therapy

A carbon dot-doped Cu-MOF-based smart nanoplatform for enhanced immune checkpoint blockade therapy and synergistic multimodal cancer therapy

Regulating the immunosuppressive tumor microenvironment to enhance breast cancer immunotherapy using pH-responsive hybrid membrane-coated nanoparticles

FeS2@COF Based Nanocarrier for Photothermal-Enhanced Chemodynamic/thermodynamic Tumor Therapy and Immunotherapy Via Reprograming Tumor-Associated Macrophages

Platelet-mimicking nanoparticles co-loaded with W18O49 and metformin alleviate tumor hypoxia for enhanced photodynamic therapy and photothermal therapy.

Biomimetic multifunctional nanodrugs enable regulating abnormal tumor metabolism and amplifying PDT-induced immunotherapy for synergistically enhanced tumor ablation

Based on polydopamine-coated metal organic framework multifunctional nanoplatform for enhanced photothermal/sonodynamicand treatment combined with checkpoint blockade therapy

A Metal-Polymer Hybrid Biomimetic System for use in the Chemodynamic-Enhanced Photothermal Therapy of Cancers

Genetically Engineering Cell Membrane‐Coated BTO Nanoparticles for MMP2‐activated Piezocatalysis‐immunotherapy

Magneto‐Electrically Enhanced Intracellular Catalysis of FePt‐FeC Heterostructures for Chemodynamic Therapy

Immunostimulatory multi-interfacial bimetallic phosphide nanoparticles as photo-enhanced cascade nanozyme for cancer therapy

Catalytically Active Metal-Organic Frameworks Elicit Robust Immune Response to Combination Chemodynamic and Checkpoint Blockade Immunotherapy.

Enhanced immunotherapy based on the synergistic click reaction-mediated chemotherapy and photothermal therapy for efficient tumor inhibition

Metformin Liposome-Mediated PD-L1 Downregulation for Amplifying the Photodynamic Immunotherapy Efficacy

Chemodynamic and Photothermal Combination Therapy Based on Dual-Modified Metal-Organic Framework for Inducing Tumor Ferroptosis/Pyroptosis

pH-sensitive tumor-tropism hybrid membrane-coated nanoparticles for reprogramming the tumor microenvironment and boosting the antitumor immunity

Macrophage-Mimic Hollow Mesoporous Fe-Based Nanocatalysts for Self-Amplified Chemodynamic Therapy and Metastasis Inhibition via Tumor Microenvironment Remodeling

Bioinspired Bimetallic Ions Functionalized MOF SAzyme Nanocomposites for Synergistic Ferroptosis/Cuproptosis-Enhanced Immune Checkpoint Therapy

Dual-responsive nanoplatform for integrated cancer diagnosis and therapy: Unleashing the power of tumor microenvironment